Ambit Health Ventures

Encapsulate is a biotechnology company focused on developing automated tumor-on-a-chip systems that facilitate personalized cancer treatment. The company's innovative technology allows for the growth of patients' cancer cells outside the body, creating micro tumors that can be preserved and utilized to assess the efficacy of various chemotherapy and biotherapeutic drugs. By screening the response profile of cancer patients to these treatments, Encapsulate aims to enable oncologists to tailor effective treatment regimens, improving outcomes in cancer care.

Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Smartlens is a clinical-stage Med Tech company focused on developing innovative technologies to diagnose and treat glaucoma, a leading cause of irreversible blindness. The company’s flagship product, miLens, is a novel eye pressure monitoring contact lens designed to provide a non-invasive and convenient solution for continuous intraocular pressure (IOP) monitoring. This technology addresses a critical need, as a significant portion of glaucoma patients remain undiagnosed, and many experience vision loss despite treatment. miLens utilizes a unique, electronics-free sensor technology, which is protected by an extensive portfolio of patents. In addition to IOP monitoring, Smartlens is exploring applications for its technology in neurological disorders and cancers at Stanford University Labs. The company also possesses a non-invasive drug delivery system that not only monitors IOP but also releases medication as needed, enhancing treatment efficacy and patient compliance. Smartlens has received recognition for its innovation, including awards for outstanding achievements in medical technology, and has been featured in various prominent media outlets.

SOAP Health is a healthcare technology company founded in 2019 and based in Boca Raton, Florida. It specializes in developing an artificial intelligence-driven platform that enhances clinical decision-making by capturing and analyzing detailed patient data prior to medical visits. The platform facilitates accurate and efficient patient-reported data collection, risk assessment, and documentation, resulting in a 90% completed SOAP Note for physicians. This system aims to improve patient care and doctor productivity while reducing liability exposure. Additionally, SOAP Health's conversational AI interface integrates with electronic health records to assess risk factors and engage patients effectively, enabling healthcare providers to identify at-risk individuals and promote early disease detection and intervention.

Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Smartlens is a clinical-stage Med Tech company focused on developing innovative technologies to diagnose and treat glaucoma, a leading cause of irreversible blindness. The company’s flagship product, miLens, is a novel eye pressure monitoring contact lens designed to provide a non-invasive and convenient solution for continuous intraocular pressure (IOP) monitoring. This technology addresses a critical need, as a significant portion of glaucoma patients remain undiagnosed, and many experience vision loss despite treatment. miLens utilizes a unique, electronics-free sensor technology, which is protected by an extensive portfolio of patents. In addition to IOP monitoring, Smartlens is exploring applications for its technology in neurological disorders and cancers at Stanford University Labs. The company also possesses a non-invasive drug delivery system that not only monitors IOP but also releases medication as needed, enhancing treatment efficacy and patient compliance. Smartlens has received recognition for its innovation, including awards for outstanding achievements in medical technology, and has been featured in various prominent media outlets.

Bone Health Technologies, Inc. is a health technology company based in Redwood City, California, focused on developing innovative solutions for individuals with low bone density. Incorporated in 2018, the company has created OsteoBoost, a wearable medical device that provides a non-invasive treatment to prevent osteoporosis. This FDA-cleared device is designed to be worn on the lower back and utilizes whole-body vibration technology to deliver mechanical stimulation to the hips and spine, mimicking the effects of weight-bearing exercise. Clinical studies have demonstrated OsteoBoost's efficacy in significantly slowing down the loss of bone density and strength, particularly in postmenopausal women with osteopenia. By offering a convenient, pain-free alternative to pharmacological treatments, Bone Health Technologies aims to improve health outcomes for the approximately 64 million Americans at risk of osteoporotic fractures.